AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance efficacy, ...
AUSTIN, Texas--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced a strategic ...
From bitter hop bombs to hazy juice and bracing Brut ales, today’s IPA family turns a 250-year-old export beer into America’s favorite style. Here’s how to find your perfect brew. IPA may be the most ...
WASHINGTON, May 7, 2025 /PRNewswire/ -- The Institute for Portfolio Alternatives (IPA) has been recognized with two major awards for its 2024 brand refresh, underscoring the organization's leadership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback